ConvaTec Group PLC (GB00BD3VFW73) | |||
2,65 GBXStand (close): 03.07.25 |
![]() |
||
Nachrichten |
||
Datum / Uhrzeit | Titel | Bewertung |
31.03.25 08:00:00 | Convatec Announces Exclusive Collaboration With Largest Wound, Ostomy and Continence Professional Nursing Organisation | ![]() |
Unique global programme and collaboration with Wound, Ostomy, and Continence Nurses Society™ (WOCN®) set to support healthcare professionals LONDON, March 31, 2025--(BUSINESS WIRE)--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, is excited to announce its global collaboration with the Wound, Ostomy, and Continence Nurses Society™ (WOCN®), the largest and most recognised professional nursing community dedicated to advancing the practice and delivery of expert healthcare to individuals with wound, ostomy, and continence care needs. Together, Convatec and WOCN are announcing two best-in-class, free, educational initiatives to enhance general ostomy care knowledge for healthcare professionals as many facilities do not have enough trained staff in this area. The two initiatives include the online Advanced Ostomy Care Program and the Ostomy Care Associates (OCA®) Program, both designed to enhance the standard of care ostomy patients receive by providing education for both specialised and non-specialised healthcare professionals. These programmes will be available* in the United States, United Kingdom, Ireland, Brazil, Poland and China in 2025, with the first programmes launching in the US, UK and Ireland. Bruno Pinheiro, President & Chief Operating Officer, Ostomy Care at Convatec said: "Forever caring is the promise we make to our customers, including patients, consumers and healthcare professionals. We are delighted to launch this new collaboration with the WOCN Society to offer education that we believe will give more patients access to best-in-class ostomy care and improve quality of life for the growing number of people living with an ostomy worldwide." Dr. Tod Brindle PhD, Medical Affairs Director, Ostomy Care at Convatec said: "Supporting healthcare professionals in this way helps Convatec achieve our mutual goals of enhancing patient care, providing access to specialised care where ostomy services are limited, and improving the quality of life for those we serve. This exciting opportunity for existing ostomy care healthcare professionals worldwide, led by our specialist teams, will enhance their knowledge and elevate the standard of care for people with an ostomy, while also striving to train over 750 new healthcare professionals to deliver specialised care to ostomates." Vittoria (Vicky) Pontieri-Lewis, MS, RN, ACNS-BC, CWOCN, President of the WOCN Society, said: "We are grateful to Convatec for making this unique programme possible. This collaboration will expand access to continuing education in ostomy care, ultimately helping individuals with ostomies benefit from current evidence-based practices and receive the optimal care they deserve." Story Continues Advanced Ostomy Care Program Convatec has curated a library of complimentary self-paced on-demand online courses developed and administered by WOCN. The courses selected were chosen by experts in ostomy care because they will help equip healthcare providers with the specialised knowledge and skills needed to offer optimal pre-operative, post-operative and ongoing care. The Ostomy Care Associate (OCA) Program WOCN recognises that many healthcare facilities do not have enough staff trained in ostomy care and developed the OCA Program to enhance the general ostomy care knowledge for the entire nursing team with the goal of improving patient outcomes. Convatec is investing in the expansion by offering it at no cost to select facilities and managing the administration of the curriculum initiative, and through highly qualified ostomy care experts. The expansion underscores Convatec’s commitment to improving knowledge for healthcare professionals and ensuring that people living with an ostomy receive superior care that improves their quality of life. All participants will receive a certificate of completion awarded by the WOCN Society. Licensed nurses in the US are eligible and will receive Contact Hours upon completing the programme. Since its inception in 2017, over 1,000 people have completed the OCA Program. Of those, 100% have reported that their professional knowledge and skills were updated, 99.6% have reported that they plan on making changes in their practice based on this educational activity, and 100% would recommend this activity to others. *Access to these programmes is being granted by an unrestricted educational grant. Notes to editors You can find more information on the UK and Ireland webpages here and on the US webpages here. About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec’s revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com About the Wound, Ostomy, and Continence Nurses Society™ Founded in 1968, the Wound, Ostomy, and Continence Nurses Society™ (WOCN®) is the largest and most recognised professional nursing community dedicated to advancing the practice and delivery of expert healthcare to individuals with wound, ostomy, and continence care needs. Through relevant education, effective advocacy, cutting-edge science, a supportive network, and a patient-centric approach, the Society enables professional growth for 5,000+ members and aids in improving patient outcomes. Visit wocn.org View source version on businesswire.com: https://www.businesswire.com/news/home/20250331342836/en/ Contacts Media: MediaRelations@convatec.com Investor relations: ir@convatec.com View Comments |
||
07.03.25 06:07:48 | UK Stocks That Might Be Trading Below Their Estimated Value In March 2025 | ![]() |
The United Kingdom's stock market has recently experienced a downturn, with the FTSE 100 index closing lower due to weak trade data from China, highlighting concerns about global economic recovery. In such an environment, identifying stocks that might be trading below their estimated value can offer potential opportunities for investors looking to capitalize on undervaluation amid broader market challenges. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) Dr. Martens (LSE:DOCS) £0.6105 £1.19 48.6% GlobalData (AIM:DATA) £1.79 £3.37 46.9% Deliveroo (LSE:ROO) £1.257 £2.50 49.6% AstraZeneca (LSE:AZN) £120.28 £219.10 45.1% Duke Capital (AIM:DUKE) £0.3025 £0.55 44.6% Likewise Group (AIM:LIKE) £0.195 £0.37 47.6% Calnex Solutions (AIM:CLX) £0.52 £1.03 49.7% Kromek Group (AIM:KMK) £0.0585 £0.11 48.5% Optima Health (AIM:OPT) £1.82 £3.31 45% Savannah Energy (AIM:SAVE) £0.105 £0.20 48.7% Click here to see the full list of 57 stocks from our Undervalued UK Stocks Based On Cash Flows screener. We'll examine a selection from our screener results. ConvaTec Group Overview: ConvaTec Group PLC develops, manufactures, and sells medical products, services, and technologies across Europe, North America, and internationally with a market cap of £5.47 billion. Operations: The company's revenue is primarily generated from the development, manufacture, and sale of medical products and technologies, amounting to $2.29 billion. Estimated Discount To Fair Value: 36% ConvaTec Group appears undervalued, trading at £2.67, 36% below its estimated fair value of £4.18. The company's earnings grew by 46.2% last year and are forecast to grow annually at 16.9%, outpacing the UK market's 14.1%. Despite high debt levels, ConvaTec maintains a strong financial position with operating profit growth projected at 12% for 2025 and a net income increase to US$190.5 million from US$130.3 million in the prior year. Our growth report here indicates ConvaTec Group may be poised for an improving outlook. Take a closer look at ConvaTec Group's balance sheet health here in our report.LSE:CTEC Discounted Cash Flow as at Mar 2025 Genus Overview: Genus plc is an animal genetics company with operations across North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa and Asia; it has a market cap of £1.25 billion. Operations: The company's revenue is derived from two main segments: Genus ABS, which contributes £311.10 million, and Genus PIC, which accounts for £358 million. Estimated Discount To Fair Value: 19% Genus plc, trading at £19.04, is undervalued relative to its fair value estimate of £23.5. Despite recent earnings showing a decline in net income to £1.5 million from £10.3 million year-on-year, analysts forecast robust profit growth of 46.67% annually over the next three years, outpacing market averages and expected to achieve profitability within this period. However, the stock exhibits high volatility and a low forecasted return on equity of 12.5%. Story Continues In light of our recent growth report, it seems possible that Genus' financial performance will exceed current levels. Delve into the full analysis health report here for a deeper understanding of Genus.LSE:GNS Discounted Cash Flow as at Mar 2025 PageGroup Overview: PageGroup plc, along with its subsidiaries, offers recruitment consultancy and related services across the UK, Europe, the Middle East, Africa, Asia Pacific, and the Americas with a market cap of £1.05 billion. Operations: PageGroup generates revenue through its recruitment consultancy and ancillary services across regions including the UK, Europe, the Middle East, Africa, Asia Pacific, and the Americas. Estimated Discount To Fair Value: 14.3% PageGroup, trading at £3.34, is undervalued compared to its fair value estimate of £3.9. Despite a decline in revenue and net income for 2024, earnings are forecast to grow significantly at 37.6% annually over the next three years, surpassing UK market averages. The company proposed a dividend increase but maintains an unstable dividend track record. Profit margins have decreased from 3.8% to 1.6%, yet return on equity is projected to be high at 35.1%. Our comprehensive growth report raises the possibility that PageGroup is poised for substantial financial growth. Unlock comprehensive insights into our analysis of PageGroup stock in this financial health report.LSE:PAGE Discounted Cash Flow as at Mar 2025 Summing It All Up Access the full spectrum of 57 Undervalued UK Stocks Based On Cash Flows by clicking on this link. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:CTEC LSE:GNS and LSE:PAGE. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments |
||
29.01.25 11:02:40 | Discover Restore And 2 Other UK Stocks That May Be Trading Below Estimated Value | ![]() |
The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, impacting companies closely tied to its economic performance. Amid these conditions, identifying stocks that may be undervalued becomes crucial as investors seek opportunities that could offer potential value despite broader market pressures. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) Hercules Site Services (AIM:HERC) £0.495 £0.93 46.5% Gaming Realms (AIM:GMR) £0.367 £0.71 48.7% GlobalData (AIM:DATA) £1.785 £3.57 49.9% On the Beach Group (LSE:OTB) £2.565 £5.03 49% ConvaTec Group (LSE:CTEC) £2.502 £4.92 49.1% Victrex (LSE:VCT) £9.89 £19.52 49.3% Informa (LSE:INF) £8.38 £16.32 48.7% Deliveroo (LSE:ROO) £1.328 £2.64 49.7% BATM Advanced Communications (LSE:BVC) £0.192 £0.38 49.4% St. James's Place (LSE:STJ) £9.47 £18.68 49.3% Click here to see the full list of 52 stocks from our Undervalued UK Stocks Based On Cash Flows screener. Let's explore several standout options from the results in the screener. Restore Overview: Restore plc, with a market cap of £295.76 million, offers services to offices and workplaces in both the public and private sectors primarily in the United Kingdom. Operations: The company's revenue is derived from Secure Lifecycle Services, contributing £104.40 million, and Digital & Information Management, generating £172.50 million. Estimated Discount To Fair Value: 29.4% Restore is trading at £2.24, significantly below its estimated fair value of £3.17, indicating potential undervaluation based on discounted cash flows. Despite slower revenue growth forecasts of 3.6% annually and flat FY24 revenue due to market uncertainty, earnings are expected to grow significantly at 48.22% per year, outpacing the UK market average. However, interest payments are not well covered by earnings and the dividend yield of 2.39% lacks coverage by current profits. According our earnings growth report, there's an indication that Restore might be ready to expand. Dive into the specifics of Restore here with our thorough financial health report.AIM:RST Discounted Cash Flow as at Jan 2025 ConvaTec Group Overview: ConvaTec Group PLC develops, manufactures, and sells medical products, services, and technologies across Europe, North America, and internationally with a market cap of £5.08 billion. Operations: The company's revenue primarily comes from the development, manufacture, and sale of medical products and technologies, totaling $2.20 billion. Estimated Discount To Fair Value: 49.1% ConvaTec Group is trading at £2.50, well below its estimated fair value of £4.92, highlighting potential undervaluation based on discounted cash flows. Earnings have grown significantly by 117.9% in the past year and are forecast to grow 20.35% annually, surpassing UK market averages. However, despite robust profit growth projections and revenue growth forecasts exceeding the UK market rate of 3.6%, ConvaTec carries a high level of debt that may impact financial flexibility. Story Continues The analysis detailed in our ConvaTec Group growth report hints at robust future financial performance. Take a closer look at ConvaTec Group's balance sheet health here in our report.LSE:CTEC Discounted Cash Flow as at Jan 2025 Vp Overview: Vp plc offers equipment rental and associated services both in the United Kingdom and internationally, with a market cap of £236.77 million. Operations: The company generates revenue through its operations in the United Kingdom, contributing £339.21 million, and international activities, adding £43.35 million. Estimated Discount To Fair Value: 38.5% Vp plc is trading at £6.20, significantly below its estimated fair value of £10.07, suggesting potential undervaluation based on discounted cash flows. Despite a high debt level and modest revenue growth forecast of 3.9% annually, Vp's profitability is expected to improve above market averages over the next three years. The recent launch of Vp Rail aligns with its strategic focus on end markets and digital enhancements, potentially supporting future growth despite current earnings not covering dividends adequately. Our expertly prepared growth report on Vp implies its future financial outlook may be stronger than recent results. Delve into the full analysis health report here for a deeper understanding of Vp.LSE:VP. Discounted Cash Flow as at Jan 2025 Seize The Opportunity Investigate our full lineup of 52 Undervalued UK Stocks Based On Cash Flows right here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Looking For Alternative Opportunities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:RST LSE:CTEC and LSE:VP.. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments |
||
06.01.25 14:00:00 | LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer | ![]() |
LONDON, January 06, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as Chief Human Resources Officer (CHRO), effective January 14. Kozmina will lead global human resources, serve on the Executive Leadership Team, and report to Vladimir Makatsaria, Chief Executive Officer. "Natalia has a deep background in the medtech and life sciences sectors and is a proven enterprise and executive leader in human resources management," Makatsaria said. "I look forward to collaborating with Natalia to further strengthen our organizational culture and build a thriving environment at LivaNova." Kozmina most recently served as Executive Vice President and CHRO of Convatec Group PLC (LSE: CTEC), a London-based global medical technologies company and constituent of the FTSE 100 Index. In this role, she developed and implemented transformative talent strategies to strengthen leadership capabilities across the business and set the foundation for building a winning culture and high-performing teams. She also served in senior human resources leadership roles for Iron Mountain (NYSE: IRM) and Smiths Group (LSE: SMIN). In April 2024, Kozmina was appointed to the Board of London-based Carclo PLC (LSE: CAR.L), a global high-precision critical components company, as a Non-Executive Director where she chairs the Remuneration Committee and is a member of the Audit and Nomination Committees. "I am delighted to join the LivaNova team during this time of solid growth and success in its clinical programs," Kozmina said. "I am eager to work with the talented teams across the enterprise to drive HR strategies that align with our values and support employees as they work to improve the lives of patients around the world." Kozmina, who will be based in Italy, has more than 25 years of global leadership experience for publicly traded companies in highly regulated industries. She spent the first half of her career in the pharmaceutical industry, serving in leadership positions for companies such as Abbott Laboratories (NYSE: ABT), DuPont Merck, and Bristol-Myers Squibb (NYSE: BMY). Kozmina holds a Master of Business Administration (MBA) degree from The University of Chicago’s Booth School of Business and earned a postgraduate degree in Chemistry from The Ohio State University. She completed her undergraduate studies in Chemistry at M.V. Lomonosov Moscow State University in Moscow, Russia. About LivaNova LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in London, LivaNova employs approximately 2,900 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals, and healthcare systems worldwide. For more information, please visit www.livanova.com. Story Continues Safe Harbor Statement This news release contains "forward-looking statements" concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding the executive leadership of the Company. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances. View source version on businesswire.com: https://www.businesswire.com/news/home/20250106082020/en/ Contacts LivaNova Investor Relations and Media Contacts +1 281-895-2382 Briana Gotlin VP, Investor Relations InvestorRelations@livanova.com Deanna Wilke VP, Corporate Communications Corporate.Communications@livanova.com View Comments |
||
20.11.24 13:05:21 | Three Stocks That May Be Trading Below Estimated Value In November 2024 | ![]() |
As global markets navigate the complexities of policy shifts under the Trump 2.0 administration, investors are witnessing significant movements across various sectors, with financials and energy gaining from deregulation hopes while healthcare and electric vehicle stocks face pressure. Amidst these changes, identifying stocks that may be trading below their estimated value becomes crucial for investors seeking opportunities in a market characterized by volatility and sector-specific fluctuations. Top 10 Undervalued Stocks Based On Cash Flows Name Current Price Fair Value (Est) Discount (Est) Taiwan Union Technology (TPEX:6274) NT$156.50 NT$311.70 49.8% Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) CN¥38.67 CN¥76.93 49.7% Giant Biogene Holding (SEHK:2367) HK$48.90 HK$97.74 50% Wistron (TWSE:3231) NT$114.00 NT$227.50 49.9% SISB (SET:SISB) THB31.75 THB63.42 49.9% ConvaTec Group (LSE:CTEC) £2.43 £4.85 49.9% Shoei (TSE:7839) ¥2360.00 ¥4718.51 50% EnomotoLtd (TSE:6928) ¥1475.00 ¥2946.42 49.9% TF Bank (OM:TFBANK) SEK312.00 SEK621.04 49.8% Credit Clear (ASX:CCR) A$0.355 A$0.71 50% Click here to see the full list of 935 stocks from our Undervalued Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Applus Services Overview: Applus Services, S.A. operates in the testing, inspection, and certification industry through its subsidiaries and has a market capitalization of approximately €1.64 billion. Operations: The company's revenue is primarily derived from its Energy & Industry segment (€1.12 billion), followed by Automotive (€394.94 million), IDIADA (€353.83 million), and Laboratories (€278.31 million). Estimated Discount To Fair Value: 14.4% Applus Services is trading at €12.7, approximately 14.4% below its estimated fair value of €14.83, suggesting it may be undervalued based on cash flows. Although the company has a high level of debt and slower revenue growth than the Spanish market, earnings are projected to grow significantly at over 50% annually. Furthermore, Applus is expected to achieve profitability within three years with a strong forecasted return on equity of 24.3%. Insights from our recent growth report point to a promising forecast for Applus Services' business outlook. Take a closer look at Applus Services' balance sheet health here in our report.BME:APPS Discounted Cash Flow as at Nov 2024 Pluk Phak Praw Rak Mae Overview: Pluk Phak Praw Rak Mae Public Company Limited specializes in cultivating organic vegetables and fruits in Thailand, with a market cap of THB93.79 billion. Operations: The company generates revenue primarily from its restaurant business, amounting to THB2.25 billion. Story Continues Estimated Discount To Fair Value: 46.2% Pluk Phak Praw Rak Mae, following its recent IPO raising THB 1.07 billion, is trading at THB 16.6, significantly below its estimated fair value of THB 30.86, highlighting potential undervaluation based on cash flows. The company anticipates robust revenue growth of 22.6% annually and earnings growth of 23.5%, outpacing the Thai market's average growth rates, despite a lower forecasted return on equity of 15.7% in three years. Our comprehensive growth report raises the possibility that Pluk Phak Praw Rak Mae is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Pluk Phak Praw Rak Mae.SET:OKJ Discounted Cash Flow as at Nov 2024 Ficont Industry (Beijing) Overview: Ficont Industry (Beijing) Co., Ltd. manufactures and supplies wind turbine tower internals and safety systems for wind turbine manufacturers in China and internationally, with a market cap of CN¥6.04 billion. Operations: The company generates revenue of CN¥1.34 billion from its Construction Machinery & Equipment segment. Estimated Discount To Fair Value: 49% Ficont Industry (Beijing) Co., Ltd. is trading at CNY 28.52, well below its estimated fair value of CNY 55.91, suggesting potential undervaluation based on cash flows. The company reported strong earnings growth of 130.5% over the past year, with future revenue expected to grow at 24.8% annually, surpassing the Chinese market average of 13.9%. However, its return on equity is forecasted to be relatively low at 16.5% in three years. Our earnings growth report unveils the potential for significant increases in Ficont Industry (Beijing)'s future results. Click here to discover the nuances of Ficont Industry (Beijing) with our detailed financial health report.SHSE:605305 Discounted Cash Flow as at Nov 2024 Turning Ideas Into Actions Delve into our full catalog of 935 Undervalued Stocks Based On Cash Flows here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:APPS SET:OKJ and SHSE:605305. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments |
||
20.11.24 11:05:30 | UK Stocks Estimated To Be Trading Below Fair Value In November 2024 | ![]() |
As the United Kingdom's FTSE 100 index grapples with downward pressures stemming from weak trade data out of China, investors are closely monitoring the broader market implications for stocks tied to global economic trends. In such a challenging environment, identifying undervalued stocks that may offer potential value becomes crucial for those looking to navigate through uncertainty and capitalize on opportunities within the UK market. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) Gaming Realms (AIM:GMR) £0.3765 £0.73 48.3% ConvaTec Group (LSE:CTEC) £2.43 £4.85 49.9% TBC Bank Group (LSE:TBCG) £32.75 £62.68 47.8% On the Beach Group (LSE:OTB) £1.584 £3.01 47.3% Redcentric (AIM:RCN) £1.165 £2.27 48.6% BATM Advanced Communications (LSE:BVC) £0.195 £0.38 48.4% Auction Technology Group (LSE:ATG) £4.48 £8.54 47.5% Foxtons Group (LSE:FOXT) £0.548 £1.03 46.8% St. James's Place (LSE:STJ) £8.255 £16.31 49.4% Genel Energy (LSE:GENL) £0.816 £1.54 46.9% Click here to see the full list of 51 stocks from our Undervalued UK Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Victorian Plumbing Group Overview: Victorian Plumbing Group plc is an online retailer specializing in bathroom products and accessories in the United Kingdom, with a market cap of £364.78 million. Operations: The company's revenue primarily comes from its online retail segment, which generated £282.90 million. Estimated Discount To Fair Value: 45.9% Victorian Plumbing Group is trading at £1.12, significantly below its estimated fair value of £2.07, indicating potential undervaluation based on cash flows. Despite high levels of non-cash earnings, the company has shown a 6.1% earnings growth over the past year and forecasts a robust 36.2% annual profit growth over the next three years, outpacing the UK market's expected growth rate of 14.7%. According our earnings growth report, there's an indication that Victorian Plumbing Group might be ready to expand. Dive into the specifics of Victorian Plumbing Group here with our thorough financial health report.AIM:VIC Discounted Cash Flow as at Nov 2024 Moonpig Group Overview: Moonpig Group PLC, with a market cap of £851.17 million, operates in the Netherlands and the United Kingdom offering online greeting cards and gifts through its subsidiaries. Operations: The company's revenue segments include £51.24 million from Greetz, £241.33 million from Moonpig, and £48.58 million from Experiences. Estimated Discount To Fair Value: 42.2% Moonpig Group is trading at £2.47, well below its estimated fair value of £4.27, highlighting potential undervaluation based on cash flows. The company forecasts a 19.21% annual earnings growth, surpassing the UK market's 14.7%. Despite high debt and recent insider selling, Moonpig's revenue growth of 7.6% annually outpaces the broader market rate of 3.5%. Recent share buybacks could further enhance shareholder value by reducing outstanding shares. Story Continues Insights from our recent growth report point to a promising forecast for Moonpig Group's business outlook. Click to explore a detailed breakdown of our findings in Moonpig Group's balance sheet health report.LSE:MOON Discounted Cash Flow as at Nov 2024 St. James's Place Overview: St. James's Place plc is a publicly owned investment manager with a market cap of £4.46 billion, focusing on providing wealth management services. Operations: The company's revenue segment is primarily derived from its Wealth Management Business, amounting to £26.80 billion. Estimated Discount To Fair Value: 49.4% St. James's Place is trading at £8.26, significantly under its fair value estimate of £16.31, suggesting it may be undervalued based on cash flows. Although revenue is projected to decline sharply over the next three years, earnings are expected to grow 27.34% annually and reach profitability within the same period, outperforming market averages. Recent share buyback activities amounting to £32.9 million could enhance shareholder value by reducing outstanding shares and increasing earnings per share potential. Our earnings growth report unveils the potential for significant increases in St. James's Place's future results. Get an in-depth perspective on St. James's Place's balance sheet by reading our health report here.LSE:STJ Discounted Cash Flow as at Nov 2024 Seize The Opportunity Investigate our full lineup of 51 Undervalued UK Stocks Based On Cash Flows right here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:VIC LSE:MOON and LSE:STJ. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments |
||
20.11.24 05:04:13 | Three Stocks That May Be Undervalued In November 2024 | ![]() |
As global markets navigate the uncertainties introduced by the incoming Trump administration, investors are keenly observing shifts in sector performance and policy impacts. With U.S. stocks retracting some gains amid these developments, identifying undervalued opportunities becomes crucial for those looking to capitalize on market fluctuations. In this context, a good stock may be one that demonstrates resilience or potential for growth despite current market volatility and policy changes. Top 10 Undervalued Stocks Based On Cash Flows Name Current Price Fair Value (Est) Discount (Est) Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) CN¥16.71 CN¥33.16 49.6% Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) CN¥38.49 CN¥76.93 50% Taiwan Union Technology (TPEX:6274) NT$156.50 NT$311.70 49.8% Wuhan Keqian BiologyLtd (SHSE:688526) CN¥14.57 CN¥29.09 49.9% ConvaTec Group (LSE:CTEC) £2.43 £4.85 49.9% TF Bank (OM:TFBANK) SEK312.00 SEK621.04 49.8% AirBoss of America (TSX:BOS) CA$4.23 CA$8.40 49.6% Saipem (BIT:SPM) €2.342 €4.65 49.6% Intellian Technologies (KOSDAQ:A189300) ₩44450.00 ₩88893.31 50% Nokian Renkaat Oyj (HLSE:TYRES) €7.408 €14.72 49.7% Click here to see the full list of 935 stocks from our Undervalued Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Solvay Overview: Solvay SA is a global provider of advanced materials and specialty chemicals, with a market cap of €3.33 billion. Operations: The company's revenue is derived from Basic Chemicals (€3.23 billion), Performance Chemicals (€2.02 billion), and Corporate & Business Services (€130 million). Estimated Discount To Fair Value: 43.3% Solvay appears undervalued, trading at €31.92, significantly below its estimated fair value of €56.27. Despite recent earnings challenges—such as a drop in net income to €19 million for Q3 2024 from €220 million the previous year—the company's forecasted high return on equity and expected profitability within three years highlight potential long-term value. However, its high debt levels and volatile share price warrant cautious consideration for investors focusing on cash flow valuation metrics. In light of our recent growth report, it seems possible that Solvay's financial performance will exceed current levels. Get an in-depth perspective on Solvay's balance sheet by reading our health report here.ENXTBR:SOLB Discounted Cash Flow as at Nov 2024 Dongsung FineTec Overview: Dongsung FineTec Co., Ltd. manufactures and sells cryogenic insulation products in South Korea, with a market cap of ₩369.88 billion. Operations: The company's revenue segments include the Gas Business, generating ₩22.17 billion, and Cooling Material, contributing ₩516.27 billion. Story Continues Estimated Discount To Fair Value: 37.4% Dongsung FineTec, trading at ₩12,740, is significantly undervalued compared to its estimated fair value of ₩20,349.99. The company's earnings have grown by 75.7% over the past year and are forecast to grow 31.2% annually—outpacing the Korean market's expected growth rate of 28.6%. Despite an unstable dividend history and slower revenue growth forecasts at 12.1%, its high projected return on equity suggests potential for long-term cash flow valuation benefits. The analysis detailed in our Dongsung FineTec growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in Dongsung FineTec's balance sheet health report.KOSDAQ:A033500 Discounted Cash Flow as at Nov 2024 Taiwan Union Technology Overview: Taiwan Union Technology Corporation manufactures and sells copper foil substrates, adhesive sheets, and multi-layer laminated boards both in Taiwan and internationally, with a market capitalization of NT$42.57 billion. Operations: The company's revenue segments include the production and distribution of copper foil substrates, adhesive sheets, and multi-layer laminated boards. Estimated Discount To Fair Value: 49.8% Taiwan Union Technology, trading at NT$156.5, is significantly undervalued with an estimated fair value of NT$311.7. Recent earnings growth of 217.9% and a forecasted annual profit increase of 23.6% highlight its robust financial health compared to the broader TW market's 19.5%. Despite high non-cash earnings and a dividend not fully covered by free cash flows, its strong return on equity projection and superior revenue growth rate underscore its investment potential based on cash flows. Insights from our recent growth report point to a promising forecast for Taiwan Union Technology's business outlook. Navigate through the intricacies of Taiwan Union Technology with our comprehensive financial health report here.TPEX:6274 Discounted Cash Flow as at Nov 2024 Summing It All Up Take a closer look at our Undervalued Stocks Based On Cash Flows list of 935 companies by clicking here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTBR:SOLB KOSDAQ:A033500 and TPEX:6274. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments |
||
15.11.24 11:07:00 | 3 UK Stocks Estimated To Be Trading At A Discount Of 11.5% To 30.6% | ![]() |
The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. Amidst these broader market fluctuations, identifying undervalued stocks can offer potential opportunities for investors looking to capitalize on discrepancies between a company's intrinsic value and its current trading price. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) Gaming Realms (AIM:GMR) £0.38 £0.73 47.9% Victorian Plumbing Group (AIM:VIC) £1.14 £2.07 45% TBC Bank Group (LSE:TBCG) £31.35 £62.68 50% ConvaTec Group (LSE:CTEC) £2.474 £4.87 49.2% On the Beach Group (LSE:OTB) £1.566 £3.00 47.7% Redcentric (AIM:RCN) £1.20 £2.26 46.8% BATM Advanced Communications (LSE:BVC) £0.19325 £0.38 48.8% Foxtons Group (LSE:FOXT) £0.544 £1.02 46.9% Auction Technology Group (LSE:ATG) £4.56 £8.52 46.5% Genel Energy (LSE:GENL) £0.818 £1.54 47% Click here to see the full list of 48 stocks from our Undervalued UK Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Bridgepoint Group Overview: Bridgepoint Group plc is a private equity and private credit firm focusing on middle market, small mid cap, small cap, growth capital investments, buyouts, syndicate debt, infrastructure, direct lending and credit opportunities with a market cap of £2.71 billion. Operations: The company's revenue is primarily derived from its Private Equity segment at £285.60 million and Private Credit segment at £74.50 million. Estimated Discount To Fair Value: 11.5% Bridgepoint Group is trading at £3.29, slightly below its estimated fair value of £3.72, indicating it may be undervalued based on cash flows. Despite a recent dilution in shares and reduced profit margins from 40.7% to 19.2%, its earnings are expected to grow significantly at 33.2% annually over the next three years, outpacing the UK market's growth rate of 14.6%. The partnership with Meristem could enhance international expansion and product offerings in agricultural solutions. Our comprehensive growth report raises the possibility that Bridgepoint Group is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Bridgepoint Group.LSE:BPT Discounted Cash Flow as at Nov 2024 Phoenix Group Holdings Overview: Phoenix Group Holdings plc operates in the long-term savings and retirement business in Europe, with a market cap of £4.94 billion. Operations: The company generates revenue from its key segments, including Retirement Solutions (£2.01 billion), while experiencing negative contributions from With-profits (-£1.56 billion), Europe & Other (-£891 million), and Pensions & Savings (-£418 million). Story Continues Estimated Discount To Fair Value: 19.9% Phoenix Group Holdings, trading at £4.95, is undervalued relative to its estimated fair value of £6.18, though not by a significant margin. Despite a forecasted annual earnings growth of 76.65%, revenue is expected to decline by 27.6% annually over the next three years. The dividend yield of 10.77% is not well covered by earnings, posing sustainability concerns. Recent leadership changes could bring strategic shifts as the company focuses on enhancing internal assets rather than divestment. In light of our recent growth report, it seems possible that Phoenix Group Holdings' financial performance will exceed current levels. Navigate through the intricacies of Phoenix Group Holdings with our comprehensive financial health report here.LSE:PHNX Discounted Cash Flow as at Nov 2024 Senior Overview: Senior plc is a company that designs, manufactures, and sells high-technology components and systems for major original equipment manufacturers in the aerospace, defense, land vehicle, and power and energy sectors globally, with a market cap of approximately £607.58 million. Operations: The company's revenue segments consist of £651.10 million from Aerospace and £333 million from Flexonics. Estimated Discount To Fair Value: 30.6% Senior plc is trading at £1.49, considerably below its estimated fair value of £2.14, highlighting its undervaluation based on discounted cash flow analysis. Earnings are projected to grow significantly at 31.5% annually over the next three years, outpacing the UK market average. Recent executive changes include Alpna Amar's upcoming appointment as CFO in May 2025, potentially bringing fresh strategic insights from her extensive experience in financial and operational roles within the industrial sector. Our earnings growth report unveils the potential for significant increases in Senior's future results. Get an in-depth perspective on Senior's balance sheet by reading our health report here.LSE:SNR Discounted Cash Flow as at Nov 2024 Make It Happen Click this link to deep-dive into the 48 companies within our Undervalued UK Stocks Based On Cash Flows screener. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:BPT LSE:PHNX and LSE:SNR. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments |
||
04.11.24 11:05:02 | 3 UK Stocks That May Be Priced Below Intrinsic Value In November 2024 | ![]() |
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting the global interconnectedness of economies. In such a climate, identifying stocks that may be priced below their intrinsic value becomes crucial for investors seeking potential opportunities amidst broader market uncertainties. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) ConvaTec Group (LSE:CTEC) £2.154 £3.91 44.9% Gaming Realms (AIM:GMR) £0.375 £0.74 49% GlobalData (AIM:DATA) £2.02 £3.75 46.1% Informa (LSE:INF) £8.146 £15.46 47.3% Redcentric (AIM:RCN) £1.20 £2.39 49.8% Mpac Group (AIM:MPAC) £4.90 £8.98 45.4% Quartix Technologies (AIM:QTX) £1.665 £3.08 45.9% Foxtons Group (LSE:FOXT) £0.584 £1.06 44.7% Auction Technology Group (LSE:ATG) £4.69 £8.44 44.5% Genel Energy (LSE:GENL) £0.754 £1.45 48% Click here to see the full list of 56 stocks from our Undervalued UK Stocks Based On Cash Flows screener. We'll examine a selection from our screener results. GB Group Overview: GB Group plc, along with its subsidiaries, offers identity data intelligence products and services across the United Kingdom, the United States, Australia, and other international markets; it has a market cap of £865.76 million. Operations: The company's revenue is derived from three main segments: Fraud (£40.20 million), Identity (£156.06 million), and Location (£81.07 million). Estimated Discount To Fair Value: 30.2% GB Group is trading at £3.43, below its estimated fair value of £4.92, indicating it may be undervalued based on cash flows. Analysts expect revenue to grow by 6.1% annually, outpacing the UK market's 3.6%. The company's earnings are forecast to grow significantly at 90.56% per year and become profitable within three years, although return on equity remains low at 3.4%. Recent announcements include upcoming sales results for October 2024. Our growth report here indicates GB Group may be poised for an improving outlook. Dive into the specifics of GB Group here with our thorough financial health report.AIM:GBG Discounted Cash Flow as at Nov 2024 Tracsis Overview: Tracsis plc, along with its subsidiaries, offers software and hardware solutions as well as data analytics/GIS services for the rail, traffic data, and transportation industries, with a market cap of £195.77 million. Operations: The company generates revenue from two main segments: Rail Technology & Services, contributing £34.59 million, and Data, Analytics, Consultancy & Events, contributing £44.80 million. Estimated Discount To Fair Value: 35.1% Story Continues Tracsis, trading at £6.45, is undervalued with a fair value estimate of £9.93 based on discounted cash flow analysis. Analysts predict earnings to grow significantly at 40.64% annually, surpassing the UK market's growth rate of 14.4%. Revenue is expected to increase by 6.3% per year, also outpacing the broader market growth of 3.6%. Despite high share price volatility recently, consensus suggests a potential price rise of 96.3%. Our comprehensive growth report raises the possibility that Tracsis is poised for substantial financial growth. Click here to discover the nuances of Tracsis with our detailed financial health report.AIM:TRCS Discounted Cash Flow as at Nov 2024 Tristel Overview: Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally, with a market cap of £200.13 million. Operations: The company's revenue is primarily derived from Hospital Medical Device Decontamination (£36.34 million) and Hospital Environmental Surface Disinfection (£3.44 million). Estimated Discount To Fair Value: 12.1% Tristel, with a trading price of £4.20, is undervalued relative to its fair value estimate of £4.78 based on discounted cash flow analysis. The company's revenue grew to £41.93 million from £36.01 million last year, while net income increased to £6.49 million from £4.46 million, reflecting robust financial health despite recent insider selling activity and a dividend not fully covered by earnings. Revenue growth is forecast at 10.3% annually, outpacing the UK market's 3.6%. According our earnings growth report, there's an indication that Tristel might be ready to expand. Navigate through the intricacies of Tristel with our comprehensive financial health report here.AIM:TSTL Discounted Cash Flow as at Nov 2024 Summing It All Up Embark on your investment journey to our 56 Undervalued UK Stocks Based On Cash Flows selection here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Contemplating Other Strategies? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:GBG AIM:TRCS and AIM:TSTL. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments |
||
15.10.24 06:06:11 | 3 UK Stocks That Could Be Trading Below Estimated Value | ![]() |
The United Kingdom market has experienced a flat performance over the last week, yet it has achieved a 7.5% rise over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this context, identifying stocks that are potentially trading below their estimated value can be an attractive opportunity for investors seeking to capitalize on future growth prospects while navigating current market conditions. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) GlobalData (AIM:DATA) £1.985 £3.72 46.6% S&U (LSE:SUS) £18.45 £36.65 49.7% Marks Electrical Group (AIM:MRK) £0.62 £1.22 49.3% Informa (LSE:INF) £8.248 £16.14 48.9% Redcentric (AIM:RCN) £1.2375 £2.41 48.6% Mpac Group (AIM:MPAC) £4.525 £8.99 49.7% BATM Advanced Communications (LSE:BVC) £0.19075 £0.37 48.3% Foxtons Group (LSE:FOXT) £0.646 £1.20 46.4% SysGroup (AIM:SYS) £0.325 £0.65 50% Genel Energy (LSE:GENL) £0.775 £1.50 48.4% Click here to see the full list of 63 stocks from our Undervalued UK Stocks Based On Cash Flows screener. We'll examine a selection from our screener results. ConvaTec Group Overview: ConvaTec Group PLC develops, manufactures, and sells medical products, services, and technologies across Europe, North America, and internationally with a market cap of £4.64 billion. Operations: The company's revenue segment focuses on the development, manufacture, and sale of medical products and technologies, generating $2.20 billion. Estimated Discount To Fair Value: 41.7% ConvaTec Group appears undervalued based on cash flows, trading at £2.27 while estimated fair value stands at £3.89, suggesting a significant discount. Analysts forecast earnings growth of 21% annually, outpacing the UK market's 14%. Despite high debt levels and modest revenue growth projections of 5.8%, recent results show improved profitability with net income rising to US$78.6 million for H1 2024 from US$55.7 million last year, supporting its undervaluation thesis. Our expertly prepared growth report on ConvaTec Group implies its future financial outlook may be stronger than recent results. Click here to discover the nuances of ConvaTec Group with our detailed financial health report. LSE:CTEC Discounted Cash Flow as at Oct 2024 Sage Group Overview: The Sage Group plc, along with its subsidiaries, offers technology solutions and services for small and medium businesses across the United States, the United Kingdom, France, and internationally, with a market cap of £10.22 billion. Operations: Revenue segments are distributed as follows: Europe generates £595 million, North America contributes £1.01 billion, and the United Kingdom & Ireland accounts for £488 million. Story continues Estimated Discount To Fair Value: 21.4% Sage Group is trading at £10.26, below its estimated fair value of £13.05, highlighting potential undervaluation based on cash flows. Revenue growth is forecasted at 7.7% annually, surpassing the UK market's 3.5%, while earnings are expected to grow by 15.1%. Despite high debt levels and recent insider selling, Sage's strategic partnership with VoPay enhances its business cloud offerings, supporting revenue growth and operational efficiency amidst a backdrop of consistent financial performance improvements. Our growth report here indicates Sage Group may be poised for an improving outlook. Delve into the full analysis health report here for a deeper understanding of Sage Group. LSE:SGE Discounted Cash Flow as at Oct 2024 S&U Overview: S&U plc operates in the United Kingdom, offering motor, property bridging, and specialist finance services, with a market cap of £224.18 million. Operations: The company generates revenue from motor finance (£88.80 million) and property bridging finance (£13.69 million) in the United Kingdom. Estimated Discount To Fair Value: 49.7% S&U is trading at £18.45, significantly below its estimated fair value of £36.65, indicating potential undervaluation based on cash flows. Despite a recent drop in net income to £9.56 million and a dividend reduction, earnings are expected to grow 23.8% annually over the next three years, outpacing the UK market's growth rate of 14%. However, debt coverage by operating cash flow remains a concern for financial stability. Upon reviewing our latest growth report, S&U's projected financial performance appears quite optimistic. Get an in-depth perspective on S&U's balance sheet by reading our health report here. LSE:SUS Discounted Cash Flow as at Oct 2024 Turning Ideas Into Actions Reveal the 63 hidden gems among our Undervalued UK Stocks Based On Cash Flows screener with a single click here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:CTEC LSE:SGE and LSE:SUS. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View comments |